Asset Planning Services (Pennsylvania)’s Teva Pharmaceuticals TEVA Stock Holding History

Asset Planning Services (Pennsylvania)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-228	Closed	-$2K	–	233
2019 Q3	$2K	Hold	228	–	–	﹤0.01%	254
2019 Q2	$2K	Hold	228	–	–	﹤0.01%	245
2019 Q1	$4K	Hold	228	–	–	﹤0.01%	238
2018 Q4	$4K	Hold	228	–	–	﹤0.01%	239
2018 Q3	$5K	Hold	228	–	–	﹤0.01%	236
2018 Q2	$6K	Hold	228	–	–	﹤0.01%	223
2018 Q1	$4K	Hold	228	–	–	﹤0.01%	242
2017 Q4	$4K	Sell	228 -399	-64%	-$6K	﹤0.01%	247
2017 Q3	$11K	Sell	627 -179	-22%	-$4.03K	0.01%	229
2017 Q2	$27K	Sell	806 -1,698	-68%	-$52.6K	0.02%	171
2017 Q1	$80K	Buy	2,504 +404	+19%	+$13.8K	0.05%	121
2016 Q4	$76K	Hold	2,100	–	–	0.06%	107
2016 Q3	$97K	Hold	2,100	–	–	0.08%	94
2016 Q2	$105K	Hold	2,100	–	–	0.09%	98
2016 Q1	$112K	Buy	2,100 +1,700	+425%	+$99.7K	0.1%	92
2015 Q4	$26K	Hold	400	–	–	0.03%	128
2015 Q3	$23K	Hold	400	–	–	0.02%	125
2015 Q2	$24K	Buy	+400	New	+$24.7K	0.02%	142

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Asset Planning Services (Pennsylvania)'s TEVA Position: Q4 2019 in Review

Asset Planning Services (Pennsylvania) sold out of Teva Pharmaceuticals (TEVA) in Q4 2019, closing a stake of 228 shares — an estimated $2K sold.

Asset Planning Services (Pennsylvania) first reported a position in TEVA in Q2 2015 and held it in 18 quarters. The position peaked at $112K in Q1 2016. 436 funds tracked by Wall St. Rank hold TEVA as of Q4 2019.

Asset Planning Services (Pennsylvania) reported no remaining Teva Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Asset Planning Services (Pennsylvania) sold 228 Teva Pharmaceuticals shares in Q4 2019, an estimated $2K.
Asset Planning Services (Pennsylvania) first reported a position in Teva Pharmaceuticals in Q2 2015 and held it in 18 quarters.
Asset Planning Services (Pennsylvania)'s Teva Pharmaceuticals position peaked at $112K in Q1 2016.
436 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2019.

Based on Asset Planning Services (Pennsylvania)'s 13F filing for Q4 2019, filed 12 Feb 2020.